Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-07 3:37 pm Purchase | 2025-12-31 | 13G | Universe Pharmaceuticals Inc. UPC | SABBY MANAGEMENT, LLC | 28,111 4.900% | 28,111 (New Position) | Filing History |
| 2026-01-07 3:05 pm Purchase | 2025-12-31 | 13G | Empery Digital Inc. EMPD | SABBY MANAGEMENT, LLC | 479,428 1.300% | 479,428 (New Position) | Filing History |
| 2026-01-07 2:19 pm Purchase | 2025-12-31 | 13G | BNB Plus Corp. BNBX | SABBY MANAGEMENT, LLC | 217,840 4.900% | 217,840 (New Position) | Filing History |
| 2026-01-07 12:38 pm Purchase | 2025-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | SABBY MANAGEMENT, LLC | 41,601 4.900% | 41,601 (New Position) | Filing History |
| 2026-01-07 12:03 pm Purchase | 2025-12-31 | 13G | Cyngn Inc. CYN | SABBY MANAGEMENT, LLC | 77,680 1.000% | 77,680 (New Position) | Filing History |
| 2025-01-03 8:51 pm Purchase | 2024-12-31 | 13G | Universe Pharmaceuticals Inc. UPC | SABBY MANAGEMENT, LLC | 18,180 9.900% | 18,180 (New Position) | Filing History |
| 2025-01-03 8:18 pm Purchase | 2024-12-31 | 13G | Empery Digital Inc. EMPD | SABBY MANAGEMENT, LLC | 56,034 9.900% | 56,034 (New Position) | Filing History |
| 2025-01-03 7:50 pm Purchase | 2024-12-31 | 13G | Applied DNA Sciences, Inc. APDN | SABBY MANAGEMENT, LLC | 6,966 10.000% | 6,966 (New Position) | Filing History |
| 2025-01-03 7:25 pm Purchase | 2024-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | SABBY MANAGEMENT, LLC | 2,484 9.900% | 2,484 (New Position) | Filing History |
| 2025-01-03 6:16 pm Sale | 2024-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT, LLC | 29,051 4.900% | -191,612 (-86.83%) | Filing History |
| 2025-01-03 5:59 pm Purchase | 2024-12-31 | 13G | Cyngn Inc. CYN | SABBY MANAGEMENT, LLC | 14,322 9.900% | 13,967 (+3936.54%) | Filing History |
| 2025-01-03 5:35 pm Sale | 2024-12-31 | 13G | Phunware, Inc. PHUN | SABBY MANAGEMENT, LLC | 0 0.000% | -200,132 (Position Closed) | Filing History |
| 2025-01-03 5:19 pm Sale | 2024-12-31 | 13G | iBio, Inc. IBIO | SABBY MANAGEMENT, LLC | 19,250 0.200% | -181,053 (-90.39%) | Filing History |
| 2025-01-03 4:35 pm Sale | 2024-12-31 | 13G | TransGlobe Energy Corporation TGA | SABBY MANAGEMENT, LLC | 0 0.000% | -5,338,587 (Position Closed) | Filing History |
| 2025-01-03 4:17 pm Purchase | 2024-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT, LLC | 36,135 4.900% | 34,823 (+2653.29%) | Filing History |
| 2025-01-03 3:54 pm Sale | 2024-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | SABBY MANAGEMENT, LLC | 60,325 4.900% | -12,152 (-16.77%) | Filing History |
| 2025-01-03 3:31 pm Purchase | 2024-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | SABBY MANAGEMENT, LLC | 27,587 4.900% | 27,143 (+6116.33%) | Filing History |
| 2025-01-03 2:56 pm Purchase | 2024-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | SABBY MANAGEMENT, LLC | 13,063 0.700% | 11,436 (+703.06%) | Filing History |
| 2025-01-03 2:12 pm Purchase | 2024-12-31 | 13G | Fangdd Network Group Ltd. DUO | SABBY MANAGEMENT, LLC | 80,031 4.900% | 80,024 (+1199503.78%) | Filing History |
| 2025-01-03 1:38 pm Purchase | 2024-12-31 | 13G | GlucoTrack, Inc. GCTK | SABBY MANAGEMENT, LLC | 539 4.900% | 191 (+55.01%) | Filing History |